WASHINGTON, May 5, 2011 /PRNewswire-USNewswire/ — Today, the
Consumer Healthcare Products Association (CHPA), representing the
makers of over-the-counter (OTC) single-ingredient liquid pediatric
acetaminophen medicines, announces plans to convert these pediatric
products to just one concentration. While the transition is taking
place, starting in mid-2011, parents and caregivers can continue to
use their current products with confidence as current labeling and
dosing instructions for these children’s medicines are accurate for
safe and appropriate use.
Presently, families can purchase more than one concentration of
single-ingredient pediatric liquid acetaminophen medicines in the
United States. This voluntary change means the current children’s
strength of liquid acetaminophen (160 mg / 5 mL) will become the
only liquid concentration available for all children under
12-years-old, and the current concentrated infant drops will no
longer be sold.
“CHPA member companies are voluntarily making this conversion to
one concentration to help make it easier for parents and caregivers
to appropriately use single-ingredient liquid acetaminophen,” said
CHPA President and CEO Scott Melville. “We are committed to
providing parents and caregivers with the tools and information
they need to help give their children the right amount of these
medicines.”
CHPA and its members will be working to ensure healthcare
providers have the information they need to help answer parents’
questions about the change. During the transition, the makers of
these medicines also will work with retailers to ensure that, as
the new medicines are introduced, the more concentrated infant
drops will be removed from store shelves.
It is important to be aware that there will be a time period
when both concentrations of infants’ acetaminophen liquid products
(the concentrated drops and the new 160 mg / 5 mL concentration)
will be available in stores and in medicine cabine
‘/>”/>
